Theraclion

Theraclion Current Liabilities

The Current Liabilities of Theraclion (ALTHE.PA) as of Nov 4, 2026 is 3.59 M EUR. In the previous year, Current Liabilities was 4.51 M EUR — a change of -20.37% (lower).

Current Liabilities

3.59 MEUR

YoY

-20.37%

Last updated:

Current Liabilities of Theraclion is 2025 3.59 M EUR. Current Liabilities of Theraclion was 2024 4.51 M EUR. It decreases by -20.37% lower compared to the previous year.

The Theraclion Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
3.97 M EUR
Jan 1, 2019
4.90 M EUR
Jan 1, 2020
2.89 M EUR
Jan 1, 2021
4.28 M EUR
Jan 1, 2022
4.93 M EUR
Jan 1, 2023
9.62 M EUR
Jan 1, 2024
4.51 M EUR
Jan 1, 2025
3.59 M EUR
The Theraclion Current Liabilities history
YEARCurrent LiabilitiesYoY
3.59 MEUR-20.37%
4.51 MEUR-53.06%
9.62 MEUR+95.05%
4.93 MEUR+15.25%
4.28 MEUR+47.84%
2.89 MEUR-41.00%
4.90 MEUR+23.49%
3.97 MEUR-5.05%
4.18 MEUR-15.89%
4.97 MEUR+22.34%
4.06 MEUR+82.45%
2.23 MEUR-69.64%
7.34 MEUR+338.91%
1.67 MEUR-15.69%
1.98 MEUR+91.86%
1.03 MEUR-59.47%
2.55 MEUR+1,659.20%
144,952.08EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Theraclion Stock analysis

What does Theraclion do? Theraclion SA is a French medical company specializing in the development and production of innovative therapy systems. The company was founded in 2004 and is headquartered in Malakoff, France. Theraclion's business model is based on the development and marketing of medical devices based on High Intensity Focused Ultrasound (HIFU) technology. This technology uses ultrasound pulses to treat targeted areas in the body without the need for surgical intervention. Theraclion specializes in three main areas: oncology, dermatology, and aesthetics. In the field of oncology, Theraclion has developed the Echopulse system, which is used for the treatment of breast tumors. The system applies high-intensity ultrasound pulses to kill tumor cells without damaging surrounding tissue. This non-invasive method of tumor treatment is very promising and has already shown promising results in several studies. In the field of dermatology, Theraclion has developed the Echovist system, which is used for the treatment of nevi (moles). The system also utilizes HIFU technology to destroy the nevi, resulting in a significant improvement in the aesthetic appearance of the skin. In the field of aesthetics, Theraclion has developed the Sonovein system, which is used for the treatment of varicose veins. The system also utilizes HIFU technology to close the veins and thus improve the patient's appearance and quality of life. Theraclion has experienced impressive growth in recent years and is now an important player in the medical industry. The company has filed several patents and works closely with leading doctors and research institutions to maximize the effectiveness of its products. Overall, Theraclion aims to offer innovative therapies that meet the needs of patients and help them lead fulfilling lives. The company is committed to continuously improving its products and services and strives to achieve even greater successes in the future. Theraclion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Theraclion stock

Current Liabilities of Theraclion is 3.59 M EUR in 2025.

Current Liabilities of Theraclion changed from 4.51 M EUR to 3.59 M EUR, representing a -20.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Theraclion since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Theraclion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Theraclion

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Theraclion